„Production of Lentivirus particles pseudotyped with SARS-CoV-2 spike protein for neutralisation or drug antiviral activity assays”. One Health & Risk Management , decembrie 2023, p. 77, https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/657.